NCT01729975

Brief Summary

The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Nidek Specular Microscope CEM-530. The secondary objective is to evaluate any adverse events found during the clinical study.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 7, 2012

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 21, 2012

Completed
Last Updated

November 21, 2012

Status Verified

November 1, 2012

Enrollment Period

Same day

First QC Date

November 7, 2012

Last Update Submit

November 19, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Corneal and Endothelial Cell Measurements

    Substantial equivalence to a predicate device with respect to corneal and endothelial cell measurements

    single time point - 1 day

Study Arms (3)

18-28 years old Non-pathologic

29-80 years old Non-Pathologic

29-80 years old pathologic corneal disease

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Ophthalmology Practice

You may qualify if:

  • Non-Pathologic: Male or female subjects from 18 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who follow the instructions by Principal/Clinical investigator or clinical staff at the clinical site, and can visit on a scheduled examination date.
  • Pathologic: Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who follow the instructions by Principal/Clinical investigator or clinical staff at the clinical site, and can visit on a scheduled examination date and subjects who have any of the following conditions:
  • History of Post-op surgical trauma including, Psudophakic or Aphakic blous keratopathy or glaucoma surgery
  • History of corneal transplant
  • Physical injury or trauma to the cornea
  • Long term Fuch's dystrophy/Guttata (and other corneal endothelial dystrophy)
  • Keratoconus
  • Long term PMMA contact lens use

You may not qualify if:

  • Non-Pathologic subjects who have the following conditions:
  • Long term Diabetes
  • Dementia
  • Subjects who have other life threatening and/or debilitating systemic diseases
  • History of corneal transplant
  • Long term Fuch's dystrophy (and other corneal endothelial dystrophy)
  • Keratoconus
  • Guttata
  • Diabetic retinopathy
  • History of cataract or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device.
  • All contact lens wearers
  • Pathologic subjects who have Dementia or who have other life threatening and/or debilitating systemic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Andover Eye Associates

Andover, Massachusetts, 01810, United States

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2012

First Posted

November 21, 2012

Study Start

October 1, 2012

Primary Completion

October 1, 2012

Last Updated

November 21, 2012

Record last verified: 2012-11

Locations